Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

Vardhman Special Steels Fund Raise of ₹384.9 Cr

Vardhman Special Steels Limited submitted its Monitoring Agency Report for the quarter ended March 31, 2026. CRISIL Ratings Limited monitored the utilization of ₹384.91 Crore raised via preferential issue. Funds are being deployed towards a greenfield plant in Ludhiana, existing plant CAPEX, and working capital repayment, with ₹200.96 Crore currently unutilized and invested in low-risk instruments.

Key figures
Value₹384.9 Cr
Source

BSE filing, NSE: VSSL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vardhman Special Steels Ltd: key numbers

Share price
₹362.80
Market cap
₹3,511 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹122.0 Cr
P/E (TTM)
21.8×Sector 17.1×
Promoter holding
51.18%+0.12% QoQ
FII holding
0.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vardhman Special Steels Ltd

All →

Other fund raise announcements

All →
17:43 IST BSE
Fund RaiseUpsurge Investment & Finance Ltd USAL

Upsurge Investment & Finance Fund Raise of ₹20 Cr

Upsurge Investment & Finance approved unaudited Q2 FY27 results, appointed Manish Kabra as CFO, and approved raising up to Rs.20 Crore. The raise needs shareholder and regulatory approvals before proceeding.

Value
₹20.00 Cr
13:13 IST BSE
Fund RaiseAGI Infra Ltd AGIIL

AGI Infra Fund Raise

AGI Infra shareholders approved a special resolution to raise funds via QIP through postal ballot. Votes in favour were 100% of votes polled; no amount stated.

19:50 IST BSE
Fund RaisePajson Agro India Ltd 544657

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value
₹354.5 Cr
19:15 IST BSE
Fund RaiseEvonile Pharma Ltd EVONILE

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value
₹900.0 Cr